Drug Companies Paid To Attend FDA Advisory Panel Meeting On Painkillers’ Safety And Effectiveness
The Washington Post: Pharmaceutical Firms Paid To Attend Meeting Of Panel That Advises FDA
A scientific panel that shaped the federal government’s policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical companies that paid hundreds of thousands of dollars for the chance to affect the thinking of the Food and Drug Administration, according to hundreds of e-mails obtained by a public records request. The e-mails show that the companies paid as much as $25,000 to attend any given meeting of the panel, which had been set up by two academics to provide advice to the FDA on how to weigh the evidence from clinical trials. A leading FDA official later called the group “an essential collaborative effort” (Whoriskey, 10/6).